Gene: OPN3
Official Full Name: opsin 3provided by HGNC
Gene Summary: Opsins are members of the guanine nucleotide-binding protein (G protein)-coupled receptor superfamily. In addition to the visual opsins, mammals possess several photoreceptive non-visual opsins that are expressed in extraocular tissues. This gene, opsin 3, is strongly expressed in brain and testis and weakly expressed in liver, placenta, heart, lung, skeletal muscle, kidney, and pancreas. The gene may also be expressed in the retina. The protein has the canonical features of a photoreceptive opsin protein. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO29096 | OPN3 Knockout cell line (HeLa) | Human | OPN3 | 1:3~1:6 | Negative | Online Inquiry |
KO29097 | OPN3 Knockout cell line (HCT 116) | Human | OPN3 | 1:2~1:4 | Negative | Online Inquiry |
KO29098 | OPN3 Knockout cell line (HEK293) | Human | OPN3 | 1:3~1:6 | Negative | Online Inquiry |
KO29099 | OPN3 Knockout cell line (A549) | Human | OPN3 | 1:3~1:4 | Negative | Online Inquiry |
OPN3 Gene Knockout Cell Lines are advanced cellular models specifically engineered to lack the OPN3 gene, which encodes for the protein opsin 3, a G-protein coupled receptor found in various tissues, including the eye, brain, and other sensory organs. These specialized cell lines allow researchers to explore the biological functions of OPN3 and investigate its roles in processes such as light perception, circadian rhythms, and various signaling pathways. By eliminating the OPN3 protein, researchers can assess the molecular underpinnings of related physiological responses, creating opportunities to discover novel therapeutic targets for a multitude of diseases.
The primary mechanism of action involves the generation of knockout models through homologous recombination, leveraging CRISPR/Cas9 technology for precise gene editing. This results in a complete ablation of OPN3 expression, enabling robust studies in diverse models—ranging from neurobiology to endocrinology. The OPN3 Gene Knockout Cell Lines are invaluable for applications such as drug screening, pathway analysis, and biomarker discovery, providing insights into how receptor signaling may contribute to pathological states.
These cell lines stand out in the market because of their precise gene editing, reproducibility, and specificity of the knockout phenotype, making them more reliable than traditional models that may exhibit variable expression or residual activity of the target gene. Moreover, with growing evidence implicating OPN3 in pain modulation and neurodegenerative diseases, these cell lines position researchers at the forefront of innovative treatment strategies.
For researchers and clinicians dedicated to elucidating the complex interplay of receptor biology, the OPN3 Gene Knockout Cell Lines offer unparalleled advantages in both basic and translational research environments. By integrating cutting-edge gene editing methodologies, our company has a proven track record in providing high-quality biological products and a commitment to advancing scientific knowledge.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.